TE Tirzepatide Editorial

Governance

Author Directory

Released: · Last reviewed:

Direct answer

Pages on this site are researched and drafted by Dr. Parmis (Dr. Parmis Mojarab), Medical Researcher, Western University of Health Sciences, and every page is medically reviewed by Dr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC) before publication. Author and reviewer roles are kept distinct: authorship covers research and drafting, review covers clinical accuracy.

Key takeaways

  • Pages are researched and drafted by Dr. Parmis, Medical Researcher, and published under Tirzepatide Editorial.
  • Every page is medically reviewed by both named reviewers, Dr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC).
  • Authorship and clinical review are distinct roles and are recorded separately.
  • Reviewer identities, credentials, and NPI verification are published in the reviewer directory.
  • No content is attributed to a fabricated author or a stock persona.
Key facts
Researched byDr. Parmis — Medical Researcher, Western University of Health Sciences
Clinical reviewDr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC) — every page
Role separationAuthorship and clinical review are recorded separately
Fabricated authorsNot used
Review datesDisplayed separately from publication dates
Verified
Medical reviewers Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Released 2026-07-22
Updated
Methodology v4.1

Why separate authorship from clinical review?

Because they answer different questions. Authorship records who researched and wrote a page. Clinical review records that a qualified clinician checked the medical statements against labelling and the literature. Merging them lets a site imply clinical oversight it may not have, which is why the roles and their dates are stored and displayed separately here.

On fabricated bylines. Health sites sometimes attribute content to invented experts or stock photographs. This site does not. Every page names its researcher and both medical reviewers, each with a profile.

How much of this site's data is actually verified?

Trials with full identifiers8Trials partially verified1Trials withheld pending audit1Providers with a standing all-in price15Providers listed with a reason28$/month
The published state of every dataset behind this site. Of 43 provider records in the November 8, 2026 index, 15 publish a standing all-in price; the other 28 are listed with the reason (18 print a figure that is not like-for-like, 10 have no comparable price) rather than being quietly estimated.
Data for: Verification state of the published datasets
GroupRecords
Trials with full identifiers8
Trials partially verified1
Trials withheld pending audit1
Providers with a standing all-in price15
Providers listed with a reason28
Evidence statuses applied across every page and dataset
Evidence statusDefinitionWhat may be published
VerifiedChecked against a primary source with a recorded dateThe claim, with its identifier and date
Partially verifiedSome elements confirmed, others outstandingConfirmed elements only; the rest labelled
Verification PendingNot yet checked against a primary sourceNo factual assertion — the gap is shown

What does this page cover, and what does it deliberately leave out?

This page addresses Verified authors, experience and articles and conflicts, organised around the primary question of tirzepatide authors. Each of those elements is treated separately below rather than blended, because they carry different evidence weights and a reader is entitled to know which parts rest on randomised data and which rest on a captured commercial claim or a regulatory document.

Scope of this page and the basis for each element
ElementTreatment hereEvidence basis
Verified authorsCovered on this pageRegulatory or policy source
ExperienceCovered on this pageRegulatory or policy source
Articles and conflictsCovered on this pageRegulatory or policy source
Individualized clinical instructionDeliberately not coveredBelongs with the corrections process

What are the limits of what this page can tell you?

Every page on this site rests on a specific published policy, and that record has boundaries worth stating plainly rather than leaving a reader to discover them. The limitations below are specific to the material presented above.

Specific limitations.
  • The evidence here describes groups, populations, or captured records — it does not describe you, and no page can substitute for the corrections process.
  • Figures carry the date on which they were verified. In a market where terms change frequently, an undated figure functions as a claim about the present that nobody has checked.
  • Elements marked Verification Pending are genuinely unknown to this publication rather than merely omitted for brevity, and should not be inferred from surrounding content.
  • Where a source conflicts with another, this site shows the conflict rather than resolving it, which means some questions are left open on purpose.

What would change the conclusion on this page?

This page would be revised, with the change recorded in its history, if any of the following occurred:

  • New primary evidence bearing directly on tirzepatide authors.
  • A change to FDA labelling affecting any statement made above.
  • A verified correction submitted through the corrections process and accepted on the evidence.
  • A material change to a captured record, including a price, term, or regulatory status.
  • Completion of a verification currently marked pending, which would replace a gap with a stated fact.

Frequently asked questions

Who writes the content?

Pages are researched and drafted by Dr. Parmis, Medical Researcher, Western University of Health Sciences.

Who checks medical accuracy?

Both named medical reviewers — Dr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC) — listed in the reviewer directory.

Are authors and reviewers the same people?

No — the roles are separate and recorded separately.

Do you use fabricated author profiles?

No.

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.

Change history

Substantive changes to this page
DateChange
2026-07-22Page published with current dataset snapshot.
2026-09-04Shared cost components and disclosures rebuilt from the 2026-09-04 dataset (NexLife September 2026 card re-read live; Yucca Health and a program since removed from this site added; NexLife disclosed as a commercial partner, labelled where it appears).
2026-11-08Authorship restated: pages are researched and drafted by Dr. Parmis, Medical Researcher, and medically reviewed by both Dr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC) (previously attributed to an unnamed editorial team). Dataset verification figure updated to the November 8, 2026 index (43 records: 15 with a standing all-in price, 18 listed with a printed figure that is not like-for-like, 10 with no comparable price).

Dates change only for substantive edits, never for cosmetic changes. Corrections: corrections policy.

What else is in this section?